Home    eJManager.com Add Your Journal   |    Follow on Twitter   |    Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research



CLINICAL EVALUATION OF VANGA BHASMA IN THE MANAGEMENT OF MADHUMEHA (TYPE-2 DIABETES MELLITUS)

B. J. PATGIRI, DARSHAN K. PARMAR, P. K. PRAJAPATI.

Abstract
Introduction: Madhumeha is a Vataja type of Tridoshaja disease. Vanga is used
abundantly in practice of Ayurveda for the treatment of Madhumeha. It is a drug of choice for the
management of Madhumeha (DM-II). Guduchi Ghana ( aqueous extract of Tinospora cordifolia
(Willd.) Miers) of is also having Mehahara effect and old honey is also to be claimed for Mehaghna
properties. Material and methods: In present study total 64 patients were registered. Out of them
in Group A total 32 patients were managed with Vanga Bhasma (250 mg) along with Guduchi
Ghana (250 mg) + Old Honey (3 ml) as Sahapana whereas in Group B, 32 patients were managed
with Guduchi Ghana (250 mg) + Old Honey (3 ml) for 28 days. Observations and Results: Present
study 14%, 28% and 10% of patients markedly improvement, moderate improvement, mildly
improvement were found in Group A respectively. While 2%, 10% and 24% markedly improvement,
moderate improvement, and mildly improvement were found in Group B respectively. Overall
result showed that Vanga Bhasma possesses the antihyperglycemic effect along with its Sahapana
and it doesn’t have hypoglycemic effect. Conclusion: Vanga Bhasma with Sahapana (Guduchi
Ghana) was found moderate anti-hyperglycemic agent in the patients of Madhumeha (Type-2
Diabetes Mellitus)).

Key words: yurvedic treatment; Diabetes mellitus; Guduchi Ghana; Madhumeha; Madhu; Honey; Vanga Bhasma.



Share this Article




ScopeMed Home
Follow ScopeMed on Twitter
Article Tools
Job Opportunities/Service Offers
eJManager OJMS
eJPort Journal Hosting
About ScopeMed
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of eJManager LLC Publishing for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons